Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
Synchrony announced that its CareCredit patient financing solution is now fully integrated into Clover point‑of‑sale systems, enabling more than 40,000 health and wellness providers to process patient financing end‑to‑end within their Clover devices.